These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 33090569)
1. EphA4 regulates Aβ production via BACE1 expression in neurons. Tamura K; Chiu YW; Shiohara A; Hori Y; Tomita T FASEB J; 2020 Dec; 34(12):16383-16396. PubMed ID: 33090569 [TBL] [Abstract][Full Text] [Related]
2. Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease. Ye X; Feng T; Tammineni P; Chang Q; Jeong YY; Margolis DJ; Cai H; Kusnecov A; Cai Q J Neurosci; 2017 Mar; 37(10):2639-2655. PubMed ID: 28159908 [TBL] [Abstract][Full Text] [Related]
3. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models. Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932 [TBL] [Abstract][Full Text] [Related]
4. BACE1 Cleavage Site Selection Critical for Amyloidogenesis and Alzheimer's Pathogenesis. Zhang S; Wang Z; Cai F; Zhang M; Wu Y; Zhang J; Song W J Neurosci; 2017 Jul; 37(29):6915-6925. PubMed ID: 28626014 [TBL] [Abstract][Full Text] [Related]
5. Ginsenoside Rg1 attenuates β-amyloid generation via suppressing PPARγ-regulated BACE1 activity in N2a-APP695 cells. Chen LM; Lin ZY; Zhu YG; Lin N; Zhang J; Pan XD; Chen XC Eur J Pharmacol; 2012 Jan; 675(1-3):15-21. PubMed ID: 22166376 [TBL] [Abstract][Full Text] [Related]
6. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis. Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065 [TBL] [Abstract][Full Text] [Related]
7. SEPT8 modulates β-amyloidogenic processing of APP by affecting the sorting and accumulation of BACE1. Kurkinen KM; Marttinen M; Turner L; Natunen T; Mäkinen P; Haapalinna F; Sarajärvi T; Gabbouj S; Kurki M; Paananen J; Koivisto AM; Rauramaa T; Leinonen V; Tanila H; Soininen H; Lucas FR; Haapasalo A; Hiltunen M J Cell Sci; 2016 Jun; 129(11):2224-38. PubMed ID: 27084579 [TBL] [Abstract][Full Text] [Related]
8. Reduction of the expression of the late-onset Alzheimer's disease (AD) risk-factor Andrew RJ; De Rossi P; Nguyen P; Kowalski HR; Recupero AJ; Guerbette T; Krause SV; Rice RC; Laury-Kleintop L; Wagner SL; Thinakaran G J Biol Chem; 2019 Mar; 294(12):4477-4487. PubMed ID: 30692199 [TBL] [Abstract][Full Text] [Related]
9. Lack of BACE1 S-palmitoylation reduces amyloid burden and mitigates memory deficits in transgenic mouse models of Alzheimer's disease. Andrew RJ; Fernandez CG; Stanley M; Jiang H; Nguyen P; Rice RC; Buggia-Prévot V; De Rossi P; Vetrivel KS; Lamb R; Argemi A; Allaert ES; Rathbun EM; Krause SV; Wagner SL; Parent AT; Holtzman DM; Thinakaran G Proc Natl Acad Sci U S A; 2017 Nov; 114(45):E9665-E9674. PubMed ID: 29078331 [TBL] [Abstract][Full Text] [Related]
10. SUMO1 modulates Aβ generation via BACE1 accumulation. Yun SM; Cho SJ; Song JC; Song SY; Jo SA; Jo C; Yoon K; Tanzi RE; Choi EJ; Koh YH Neurobiol Aging; 2013 Mar; 34(3):650-62. PubMed ID: 22975420 [TBL] [Abstract][Full Text] [Related]
11. Increased NF-κB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease. Chen CH; Zhou W; Liu S; Deng Y; Cai F; Tone M; Tone Y; Tong Y; Song W Int J Neuropsychopharmacol; 2012 Feb; 15(1):77-90. PubMed ID: 21329555 [TBL] [Abstract][Full Text] [Related]
12. Disrupted-in-Schizophrenia-1 Attenuates Amyloid-β Generation and Cognitive Deficits in APP/PS1 Transgenic Mice by Reduction of β-Site APP-Cleaving Enzyme 1 Levels. Deng QS; Dong XY; Wu H; Wang W; Wang ZT; Zhu JW; Liu CF; Jia WQ; Zhang Y; Schachner M; Ma QH; Xu RX Neuropsychopharmacology; 2016 Jan; 41(2):440-53. PubMed ID: 26062786 [TBL] [Abstract][Full Text] [Related]
13. MiR-16 attenuates β-amyloid-induced neurotoxicity through targeting β-site amyloid precursor protein-cleaving enzyme 1 in an Alzheimer's disease cell model. Zhong Z; Yuan K; Tong X; Hu J; Song Z; Zhang G; Fang X; Zhang W Neuroreport; 2018 Nov; 29(16):1365-1372. PubMed ID: 30142113 [TBL] [Abstract][Full Text] [Related]
14. RTN4B-mediated suppression of Sirtuin 2 activity ameliorates β-amyloid pathology and cognitive impairment in Alzheimer's disease mouse model. Wang Y; Yang JQ; Hong TT; Sun YH; Huang HL; Chen F; Chen XJ; Chen HY; Dong SS; Cui LL; Yang TL Aging Cell; 2020 Aug; 19(8):e13194. PubMed ID: 32700357 [TBL] [Abstract][Full Text] [Related]
15. The inhibitory effect of chitosan oligosaccharides on β-site amyloid precursor protein cleaving enzyme 1 (BACE1) in HEK293 APPswe cells. Dai X; Chang P; Li X; Gao Z; Sun Y Neurosci Lett; 2018 Feb; 665():80-85. PubMed ID: 29175631 [TBL] [Abstract][Full Text] [Related]